When.com Web Search

  1. Ads

    related to: dragonfly therapeutics stock price

Search results

  1. Results From The WOW.Com Content Network
  2. Bristol Myers & Dragonfly Team Up for Immunotherapy Program

    www.aol.com/news/bristol-myers-dragonfly-team...

    For premium support please call: 800-290-4726 more ways to reach us

  3. David H. Raulet - Wikipedia

    en.wikipedia.org/wiki/David_H._Raulet

    David H. Raulet. David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. [ 1] He was elected to the National Academy of ...

  4. Martin Shkreli - Wikipedia

    en.wikipedia.org/wiki/Martin_Shkreli

    On February 1, 2011, in a naked short sale on an account it held with Merrill Lynch, MSMB Capital sold short 32 million shares of Orexigen Therapeutics stock at about $2.50 per share the day after its price plunged from $9.09, when the Food and Drug Administration (FDA) declined to approve the drug naltrexone/bupropion (Contrave).

  5. Avimech Dragonfly DF-1 - Wikipedia

    en.wikipedia.org/wiki/Avimech_Dragonfly_DF-1

    The Avimech Dragonfly DF-1 is an American helicopter produced by Avimech International Aircraft, Inc. of Tucson, Arizona. Originally developed in Switzerland , the aircraft is supplied complete and ready-to-fly.

  6. Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock ...

    www.aol.com/amgen-vs-viking-therapeutics-whats...

    If you're a risk-averse investor looking for GLP-1 exposure, then Amgen is definitely the better option at this point. It's not just a safer bet, either. MariTide's promising results in early ...

  7. Why Summit Therapeutics Stock Is Soaring Again Today - AOL

    www.aol.com/finance/why-summit-therapeutics...

    September 12, 2024 at 11:53 AM. Shares of Summit Therapeutics (NASDAQ: SMMT) were soaring 22.5% higher as of 11:18 a.m. ET on Thursday. The gain came after the clinical-stage biopharmaceutical ...